Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02252588Phase 2Completed
A Phase 2 trial of chlorhexidine in chronic obstructive pulmonary disease (COPD), sponsored by University of Minnesota. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02252588.